Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Grifols, S.A Change in Inventories 2012-2025 | GRFS

Grifols, S.A annual/quarterly change in inventories history and growth rate from 2012 to 2025. Change in inventories can be defined as the increase or decrease in a company's inventories for the period.
  • Grifols, S.A change in inventories for the quarter ending March 31, 2025 was $-0.064B, a 73.64% decline year-over-year.
  • Grifols, S.A change in inventories for the twelve months ending March 31, 2025 was $-0.577B, a 20.27% decline year-over-year.
  • Grifols, S.A annual change in inventories for 2024 was $0.028B, a 106.04% decline from 2023.
  • Grifols, S.A annual change in inventories for 2023 was $-0.462B, a 26.91% decline from 2022.
  • Grifols, S.A annual change in inventories for 2022 was $-0.632B, a 239.45% increase from 2021.
  
Grifols, S.A Annual Change in Inventories
(Millions of US $)
2024 $28
2023 $-462
2022 $-632
2021 $-186
2020 $188
2019 $-363
2018 $-274
2017 $-187
2016 $-191
2015 $-134
2014 $N/A
2013 $N/A
2012 $N/A
2011 $N/A
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $6.834B $7.805B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $76.319B 28.63
Zoetis (ZTS) United States $66.158B 24.68
Takeda Pharmaceutical (TAK) Japan $45.915B 9.13
Daiichi Sankyo, - (DSNKY) Japan $45.464B 23.30
BeOne Medicines - (ONC) Cayman Islands $32.283B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.049B 0.00
Summit Therapeutics (SMMT) United States $19.458B 0.00
Merck (MKKGY) Germany $16.692B 12.23
Shionogi (SGIOY) Japan $14.207B 0.00
United Therapeutics (UTHR) United States $13.172B 11.65
Neurocrine Biosciences (NBIX) United States $13.065B 44.75
Orion OYJ (ORINY) Finland $10.973B 26.45
IPSEN (IPSEY) France $10.477B 0.00
Stevanato Group S.p.A (STVN) Italy $7.541B 46.11
Corcept Therapeutics (CORT) United States $7.514B 61.09
Madrigal Pharmaceuticals (MDGL) United States $7.419B 0.00
Ionis Pharmaceuticals (IONS) United States $6.646B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.394B 0.00
Hypermarcas (HYPMY) Brazil $3.056B 20.10
Crinetics Pharmaceuticals (CRNX) United States $2.913B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.565B 8.99
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.498B 13.51
NewAmsterdam Pharma (NAMS) Netherlands $2.492B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.095B 0.00
Ocular Therapeutix (OCUL) United States $1.805B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.802B 0.00
ARS Pharmaceuticals (SPRY) United States $1.760B 0.00
Endo (NDOI) United States $1.606B 0.00
Evotec AG (EVO) Germany $1.513B 0.00
Harrow (HROW) United States $1.317B 0.00
Guardian Pharmacy Services (GRDN) United States $1.283B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.166B 23.32
Enliven Therapeutics (ELVN) United States $1.112B 0.00
Ardelyx (ARDX) United States $1.055B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.048B 0.00
Dyne Therapeutics (DYN) United States $1.025B 0.00
Akebia Therapeutics (AKBA) United States $1.014B 0.00
Collegium Pharmaceutical (COLL) United States $1.003B 5.41
Verve Therapeutics (VERV) United States $0.973B 0.00
ProKidney (PROK) United States $0.922B 0.00
Xeris Biopharma Holdings (XERS) United States $0.799B 0.00
Cronos Group (CRON) Canada $0.775B 0.00
KalVista Pharmaceuticals (KALV) United States $0.769B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.743B 0.00
Zevra Therapeutics (ZVRA) United States $0.660B 0.00
Xencor (XNCR) United States $0.638B 0.00
Relay Therapeutics (RLAY) United States $0.600B 0.00
Elite Pharmaceuticals (ELTP) United States $0.599B 0.00
USANA Health Sciences (USNA) United States $0.565B 12.29
Theravance Biopharma (TBPH) United States $0.563B 0.00
Organogenesis (ORGO) United States $0.554B 0.00
Oruka Therapeutics (ORKA) United States $0.544B 0.00
Bioventus (BVS) United States $0.514B 13.04
Tourmaline Bio (TRML) United States $0.475B 0.00
Siga Technologies (SIGA) United States $0.472B 9.87
Aquestive Therapeutics (AQST) United States $0.417B 0.00
Savara (SVRA) United States $0.391B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.345B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.336B 9.08
Altimmune (ALT) United States $0.331B 0.00
Aldeyra Therapeutics (ALDX) United States $0.323B 0.00
Nektar Therapeutics (NKTR) United States $0.309B 0.00
Heron Therapeutics (HRTX) United States $0.294B 0.00
AleAnna (ANNA) United States $0.292B 0.00
Nature's Sunshine Products (NATR) United States $0.275B 25.20
Nanobiotix S.A (NBTX) France $0.250B 0.00
OmniAb (OABI) United States $0.238B 0.00
Esperion Therapeutics (ESPR) United States $0.232B 0.00
MediWound (MDWD) Israel $0.221B 0.00
Larimar Therapeutics (LRMR) United States $0.206B 0.00
4D Molecular Therapeutics (FDMT) United States $0.195B 0.00
China SXT Pharmaceuticals (SXTC) China $0.191B 0.00
Galectin Therapeutics (GALT) United States $0.177B 0.00
Aclaris Therapeutics (ACRS) United States $0.174B 0.00
Profound Medical (PROF) Canada $0.170B 0.00
Journey Medical (DERM) United States $0.168B 0.00
Liminatus Pharma (LIMN) United States $0.141B 0.00
Lexeo Therapeutics (LXEO) United States $0.138B 0.00
Lyell Immunopharma (LYEL) United States $0.137B 0.00
Inhibikase Therapeutics (IKT) United States $0.137B 0.00
Avita Medical (RCEL) United States $0.137B 0.00
Korro Bio (KRRO) United States $0.128B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.124B 0.00
Protara Therapeutics (TARA) United States $0.119B 0.00
Champions Oncology (CSBR) United States $0.111B 18.20
Innate Pharma SA (IPHYF) France $0.110B 0.00
Cassava Sciences (SAVA) United States $0.107B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.104B 0.00
VAXART, INC (VXRT) United States $0.101B 0.00
Cardiol Therapeutics (CRDL) Canada $0.098B 0.00
Achieve Life Sciences (ACHV) Canada $0.093B 0.00
Vivani Medical (VANI) United States $0.092B 0.00
Nutriband (NTRB) United States $0.090B 0.00
Fractyl Health (GUTS) United States $0.088B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Context Therapeutics (CNTX) United States $0.080B 0.00
Dominari Holdings (DOMH) United States $0.079B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.076B 0.00
Metagenomi (MGX) United States $0.074B 0.00
Surrozen (SRZN) United States $0.073B 0.00
Wellgistics Health (WGRX) United States $0.073B 0.00
Rafael Holdings (RFL) United States $0.072B 0.00
Pyxis Oncology (PYXS) United States $0.070B 0.00
PMV Pharmaceuticals (PMVP) United States $0.069B 0.00
Telomir Pharmaceuticals (TELO) United States $0.068B 0.00
Avalo Therapeutics (AVTX) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.064B 0.00
Inotiv (NOTV) United States $0.060B 0.00
Klotho Neurosciences (KLTO) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Unicycive Therapeutics (UNCY) United States $0.056B 0.00
ElectroCore (ECOR) United States $0.054B 0.00
Jupiter Neurosciences (JUNS) United States $0.054B 0.00
NRx Pharmaceuticals (NRXP) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 35.78
Gain Therapeutics (GANX) United States $0.048B 0.00
Prelude Therapeutics (PRLD) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
PolyPid (PYPD) Israel $0.037B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
Vivos Therapeutics (VVOS) United States $0.034B 0.00
Karyopharm Therapeutics (KPTI) United States $0.033B 0.00
FibroGen (FGEN) United States $0.031B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
Scienture Holdings (SCNX) United States $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.022B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.019B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.019B 0.00
Relmada Therapeutics (RLMD) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Plus Therapeutics (PSTV) United States $0.019B 0.00
Incannex Healthcare (IXHL) Australia $0.018B 0.00
VYNE Therapeutics (VYNE) United States $0.018B 0.00
BioVie (BIVI) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
DURECT (DRRX) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
Minerva Neurosciences (NERV) United States $0.014B 2.43
TherapeuticsMD (TXMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Aptorum Group (APM) United Kingdom $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Talphera (TLPH) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.36
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00